Skip to main content
Top
Published in: AIDS Research and Therapy 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

Hypertension among persons living with HIV/AIDS and its association with HIV-related health factors

Authors: Mawulorm K. I. Denu, Ritika Revoori, Maame Araba E. Buadu, Oluwakemi Oladele, Kofi Poku Berko

Published in: AIDS Research and Therapy | Issue 1/2024

Login to get access

Abstract

Background

Human Immunodeficiency Virus (HIV) infection remains a public health concern in many countries. The increased life expectancy in the post-Antiretroviral Therapy (ART) era has led to an increased risk of cardiovascular disease and death among Persons Living with HIV (PLHIV). Hypertension remains a significant risk factor for cardiovascular disease among PLHIV. Some studies have suggested associations between hypertension among PLHIV and HIV-related health factors.

Objective

To determine the prevalence of hypertension among PLHIV on antiretroviral medications and examine its association with HIV-related health factors.

Methods

A cross-sectional study was conducted among attendants at an adult HIV clinic. 362 study participants were selected by systematic sampling. Data on hypertension diagnosis, HIV-related health factors, sociodemographic and other traditional cardiovascular risk factors were collected using a standardized questionnaire and patient chart review. Multivariate logistic regression model was used to determine the association between hypertension and HIV-related factors, adjusting for other risk factors for hypertension.

Results

The mean age of participants was 47.9 years and majority of participants were female (77.1%). 42% of study participants had been on antiretroviral medications for > 10 years. The prevalence of hypertension was 17.4%. Age > 50 years was associated with higher odds of hypertension (aOR: 3.75, 95%CI 1.68, 8.55, p-value: 0.002). BMI in overweight and obese categories, and a history of comorbid medical conditions (diabetes, hyperlipidemia) were also associated with higher odds of hypertension (aOR: 3. 76, 95%CI 1.44, 9.81, p-value: 0.007), (aOR: 3.17, 95%CI 1.21, 8.32, p-value: 0.019) and (aOR: 14.25, 95%CI 7.41, 27.41, p-value: < 0.001) respectively. No HIV-related health factors were associated with hypertension.

Conclusion

Hypertension was a common condition among PLHIV on antiretroviral medications. No HIV-related health factors were associated with hypertension. Traditional risk factors associated with hypertension were increased age > 50 years, increased BMI, and a history of comorbid medical conditions.
Literature
1.
go back to reference World Health Organization (WHO). HIV/AIDS Fact sheet. Accessed 10 July 2022. World Health Organization (WHO). HIV/AIDS Fact sheet. Accessed 10 July 2022.
4.
go back to reference Feinstein MJ, Bahiru E, Achenbach C, et al. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117:214–20.CrossRefPubMed Feinstein MJ, Bahiru E, Achenbach C, et al. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117:214–20.CrossRefPubMed
5.
go back to reference Nüesch R, Wang Q, Elzi L, Bernasconi E, Weber R, Cavassini M, Vernazza P, Thurnheer MC, Calmy A, Battegay M, Bucher HC. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr. 2013;62(396):404. https://doi.org/10.1097/QAI.0b013e3182847cd0.CrossRef Nüesch R, Wang Q, Elzi L, Bernasconi E, Weber R, Cavassini M, Vernazza P, Thurnheer MC, Calmy A, Battegay M, Bucher HC. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr. 2013;62(396):404. https://​doi.​org/​10.​1097/​QAI.​0b013e3182847cd0​.CrossRef
10.
go back to reference Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJ, Reiss P. Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure. Clin Infect Dis. 2016;63(205):213. https://doi.org/10.1093/cid/ciw285.CrossRef Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJ, Reiss P. Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure. Clin Infect Dis. 2016;63(205):213. https://​doi.​org/​10.​1093/​cid/​ciw285.CrossRef
23.
go back to reference Pangmekeh PJ, Awolu MM, Gustave S, Gladys T, Cumber SN. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital. Cameroon Pan Afr Med J. 2019;33:87.PubMed Pangmekeh PJ, Awolu MM, Gustave S, Gladys T, Cumber SN. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital. Cameroon Pan Afr Med J. 2019;33:87.PubMed
27.
go back to reference Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, Michael D, Todd J. Prevalence, awareness and factors associated with hypertension in North West Tanzania. Glob Health Action. 2017;10(1):1321279.CrossRefPubMedPubMedCentral Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, Michael D, Todd J. Prevalence, awareness and factors associated with hypertension in North West Tanzania. Glob Health Action. 2017;10(1):1321279.CrossRefPubMedPubMedCentral
32.
go back to reference Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: evidence from the Ghana demographic and health survey. PLoS ONE. 2018;13:1–18.CrossRef Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: evidence from the Ghana demographic and health survey. PLoS ONE. 2018;13:1–18.CrossRef
40.
go back to reference Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 2018;71:422–8.CrossRefPubMed Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: coprediction and time trajectories. Hypertension. 2018;71:422–8.CrossRefPubMed
41.
go back to reference Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45–50.CrossRefPubMed Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45–50.CrossRefPubMed
43.
go back to reference Zanuzzi MG, Cattaneo MJ, López SM, Pérez Maure MLÁ, Romero CA. Hipertensión y síndrome metabólico en pacientes con virus de la inmunodeficiencia-humana Hypertension and metabolic syndrome in HIV infected patients. Medicina (B Aires). 2020;80(5):453–61.PubMed Zanuzzi MG, Cattaneo MJ, López SM, Pérez Maure MLÁ, Romero CA. Hipertensión y síndrome metabólico en pacientes con virus de la inmunodeficiencia-humana Hypertension and metabolic syndrome in HIV infected patients. Medicina (B Aires). 2020;80(5):453–61.PubMed
44.
go back to reference Muddu M, Tusubira AK, Sharma SK, Akiteng AR, Ssinabulya I, Schwartz JI. Integrated hypertension and HIV care cascades in an HIV treatment program in eastern uganda: a retrospective cohort study. JAIDS J Acquir Immune Defic Syndr. 2019;81:552–61.CrossRefPubMed Muddu M, Tusubira AK, Sharma SK, Akiteng AR, Ssinabulya I, Schwartz JI. Integrated hypertension and HIV care cascades in an HIV treatment program in eastern uganda: a retrospective cohort study. JAIDS J Acquir Immune Defic Syndr. 2019;81:552–61.CrossRefPubMed
45.
go back to reference Ameh S. Evaluation of an integrated HIV and hypertension management model in rural South Africa: a mixed methods approach. Glob Health Action. 2020;13:1750216.CrossRefPubMedPubMedCentral Ameh S. Evaluation of an integrated HIV and hypertension management model in rural South Africa: a mixed methods approach. Glob Health Action. 2020;13:1750216.CrossRefPubMedPubMedCentral
Metadata
Title
Hypertension among persons living with HIV/AIDS and its association with HIV-related health factors
Authors
Mawulorm K. I. Denu
Ritika Revoori
Maame Araba E. Buadu
Oluwakemi Oladele
Kofi Poku Berko
Publication date
01-12-2024
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2024
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-023-00576-2

Other articles of this Issue 1/2024

AIDS Research and Therapy 1/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.